Chu Montpellier

France
Comprehensive hospital services and medical research are provided.

About Chu Montpellier

Chu Montpellier is a Healthcare company based in France. Comprehensive hospital services and medical research are provided. Its website chu-montpellier.fr draws about 417 thousand monthly visits. Its focus areas include Hospitals.

Company details

Chu Montpellier functions as a university hospital in France, focused on healthcare delivery and research. A range of medical services is offered across specialties such as surgery, cardiology, oncology, and pediatrics. Medical research initiatives are undertaken, alongside educational programs for healthcare professionals. Organ donation coordination is managed, and patient support is extended from pre-admission through post-discharge phases. Operations are supported by a network of medical staff in the Montpellier region.

Key Metrics

Funding Insights of Chu Montpellier

  • Total Rounds 14
  • Last Round Grant — $115,450
  • Investors Count 1

Latest 10 of 14 funding rounds of Chu Montpellier with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2021$115,450Grant––
Oct 2020$645,891Grant––
Mar 2020$31,471Grant––
Nov 2019$15,450Grant––
Jan 2019$520,178Grant––
Jan 2018$631,474Grant––
Jun 2017$134,718Grant––
Jan 2017$911,335Grant––
Jan 2016$490,798Grant––
Sep 2015$566,639Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Chu Montpellier

Chu Montpellier has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Chu Montpellier

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Chu Montpellier

5 people are tracked at Chu Montpellier (5 in team).

NameRoleGroup
Yrina Gilhodes
Ingénieure Chargée De Projet EdolTeam
Yanis Azzouzi
Clinical Data ManagerTeam
Anne FERRER
Directrice Générale du CHU de MontpellierTeam
Pierre Joseph Escribano
Directeur Communication, Culture & MécénatTeam
Sandrine Tury
Cadre Synergie Recherche - Groupe CancerTeam
Premium access

Complete people profiles for Chu Montpellier

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Chu Montpellier

2 dated milestones of Chu Montpellier across 13 years, from founding to its latest funding, stage changes and deals.

  1. Funding First funding round.
  2. Funding Latest funding round, Grant, of $115K.

Web traffic of Chu Montpellier

The website of Chu Montpellier (chu-montpellier.fr) receives about 416.7K visits a month and ranks #117,153 among all websites worldwide, #3,487 in Health.

  • Monthly visits
    416.7K

    ▲ 9.4% vs previous month

  • Unique visitors
    149.5K

    per month

  • Global rank
    #117,153

    among all websites

  • Category rank
    #3,487

    Health · Health

Similar websites

Websites whose visitors overlap most with Chu Montpellier. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
doctolib.fr
100%
38.2M#967View details
chu-grenoble.fr
100%
228.3K#206,295View details
vidal.fr
vidal.fr
99%
#10,574–
chu-nimes.fr
chu-nimes.fr
96%
#348,525–
has-sante.fr
95%
1.3M#50,497View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Chu Montpellier

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Chu Montpellier

Chu Montpellier is headquartered in France.

Chu Montpellier functions as a university hospital in France, focused on healthcare delivery and research. A range of medical services is offered across specialties such as surgery, cardiology, oncology, and pediatrics. Medical research initiatives are undertaken, alongside educational programs for healthcare professionals. Organ donation coordination is managed, and patient support is extended from pre-admission through post-discharge phases. Operations are supported by a network of medical staff in the Montpellier region.

Chu Montpellier has 1 investor. Key investors include European Union.

The website of Chu Montpellier receives about 417 thousand visits a month and ranks #117,153 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available